NDC 63629-9263-01 - Sodium Sulfacetamide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-9263
- Requested NDC
- 63629-9263-01
- Package NDCs from labels
- 63629-9263-1, 63629-9263-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-04-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sodium Sulfacetamide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-04-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-9263-1 | Sodium Sulfacetamide | 355 g in 1 BOTTLE | LIQUID | 355 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-9263 | SODIUM SULFACETAMIDE LIQUID [BRYANT RANCH PREPACK] | 102 | Current NDC, Legacy NDC, 1 package rows | 20240511_c9f90612-32c6-44ba-85d5-82842f0e1ba9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-9263-1 | GM - Gram | 63629-9263 | 22d67659-abe4-4504-9c93-b465de7dc850 | 1 | 2022-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM SULFACETAMIDE, SULFUR | SODIUM SULFACETAMIDE 8% SULFUR 4% | Aspen Medical LLC | 4ba94e96-b107-77fe-e063-6394a90aa980 | 2026-02-21 | Warnings, Adverse reactions | 4NRT660KJQ |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Sodium Sulfacetamide | SODIUM SULFACETAMIDE | Method Pharmaceuticals, LLC | d65e777b-682b-732d-e053-2a95a90a41ad | 2026-02-12 | Warnings | 58657-477 1006107 4aad445c-77e0-b8cd-e063-6394a90afd06 d65e777b-682b-732d-e053-2a95a90a41ad 4NRT660KJQ |
| Sodium Sulfacetamide and Sulfur | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals, LLC | d35a7764-f3c6-fd1b-e053-2a95a90a8036 | 2026-02-12 | Warnings | 4NRT660KJQ |
| Sodium Sulfacetamide 9% and Sulfur 4% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d770b9e2-dbbe-c246-e053-2995a90a398d | 2026-02-12 | Warnings, Adverse reactions | 4NRT660KJQ |
| Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d770860b-ecbd-ba22-e053-2a95a90af691 | 2026-02-12 | Warnings, Adverse reactions | 4NRT660KJQ |
| Sodium Sulfacetamide 8% and Sulfur 4% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d8dcbf63-58f0-0a25-e053-2a95a90a7633 | 2026-02-12 | Warnings, Adverse reactions | 4NRT660KJQ |
| Sodium Sulfacetamide 10% and Sulfur 2% Cleanser | SULFACETAMIDE SODIUM, SULFUR | Method Pharmaceuticals | d736fbd6-4cff-bc33-e053-2a95a90a26fd | 2026-02-12 | Warnings, Adverse reactions | 4NRT660KJQ |
| SODIUM SULFACETAMIDE 10% AND SULFUR 5% Emollient Cream | SODIUM SULFACETAMIDE 10% AND SULFUR 5% EMOLLIENT CREAM | Method Pharmaceuticals, LLC | dfc5bab2-2170-606e-e053-2a95a90a3961 | 2026-02-12 | Warnings, Adverse reactions | 4NRT660KJQ |
| sulfacetamide sodium and sulfur Sodium Sulfacetamide - Sulfur | SULFACETAMIDE SODIUM AND SULFUR | Allegis Pharmaceuticals, LLC | 1aa1025f-c568-34d3-e063-6394a90a37b8 | 2026-02-11 | Warnings, Adverse reactions | 4NRT660KJQ |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.